A detailed history of Bank Of America Corp transactions in Repare Therapeutics Inc. stock. As of the latest transaction made, Bank Of America Corp holds 12,659 shares of RPTX stock, worth $35,951. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,659
Previous 10,254 23.45%
Holding current value
$35,951
Previous $33,000 30.3%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.75 - $3.99 $6,613 - $9,595
2,405 Added 23.45%
12,659 $43,000
Q2 2024

Aug 14, 2024

SELL
$3.02 - $4.7 $37,946 - $59,055
-12,565 Reduced 55.06%
10,254 $33,000
Q1 2024

May 15, 2024

BUY
$4.53 - $8.41 $5,408 - $10,041
1,194 Added 5.52%
22,819 $107,000
Q4 2023

Feb 14, 2024

BUY
$3.22 - $11.79 $40,594 - $148,636
12,607 Added 139.8%
21,625 $157,000
Q2 2023

Aug 14, 2023

SELL
$8.63 - $12.53 $72,802 - $105,703
-8,436 Reduced 48.33%
9,018 $95,000
Q1 2023

May 12, 2023

SELL
$9.32 - $15.06 $2.27 Million - $3.67 Million
-243,432 Reduced 93.31%
17,454 $171,000
Q4 2022

Feb 10, 2023

BUY
$12.5 - $18.13 $3.1 Million - $4.49 Million
247,926 Added 1913.01%
260,886 $3.84 Million
Q3 2022

Nov 14, 2022

BUY
$11.57 - $15.59 $20,478 - $27,594
1,770 Added 15.82%
12,960 $158,000
Q2 2022

Aug 12, 2022

SELL
$8.45 - $14.84 $170,951 - $300,228
-20,231 Reduced 64.39%
11,190 $156,000
Q1 2022

May 16, 2022

SELL
$11.38 - $21.88 $5,143 - $9,889
-452 Reduced 1.42%
31,421 $448,000
Q4 2021

Feb 08, 2022

BUY
$19.66 - $28.11 $166,303 - $237,782
8,459 Added 36.13%
31,873 $672,000
Q3 2021

Nov 15, 2021

BUY
$25.71 - $35.24 $477,434 - $654,406
18,570 Added 383.36%
23,414 $615,000
Q2 2021

Sep 13, 2021

BUY
$30.1 - $34.85 $145,804 - $168,813
4,844 New
4,844 $151,000

Others Institutions Holding RPTX

About Repare Therapeutics Inc.


  • Ticker RPTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,937,800
  • Market Cap $119M
  • Description
  • Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...
More about RPTX
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.